Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menko-Jan de Boer

Showing results (71-80 of 138) with videos related to

Pageof 14
Sort By:
Diabetes Care|November 24, 2011
n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetesDaan Kromhout, Johanna M Geleijnse, Janette de Goede, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 27, 2007
External validity of ST elevation myocardial infarction trials: the Zwolle studiesSaman Rasoul, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
European Heart Journal|May 10, 2006
A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trialSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
BMC Cardiovascular Disorders|March 7, 2007
Are patients with non-ST elevation myocardial infarction undertreated?Saman Rasoul, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Journal of the American College of Cardiology|April 20, 2004
Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Felix Zijlstra, et al.
Coronary Artery Disease|July 31, 2009
Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarctionSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
International Journal of Cardiology|October 18, 2011
Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary interventionSunanto Ng, Jan Paul Ottervanger, Arnoud W J van 't Hof, et al.
Diabetes Care|March 29, 2006
Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Harry Suryapranata, Jorik Timmer, et al.
The American Journal of Cardiology|May 21, 2005
Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplastyGiuseppe De Luca, Nicolette Ernst, Harry Suryapranata, et al.
American Heart Journal|November 4, 2004
Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction studyGiuseppe De Luca, Harry Suryapranata, Jan-Henk Dambrink, et al.
Pageof 14

Showing results (71-80 of 138) with videos related to

Sort By:
Pageof 14
Diabetes Care|November 24, 2011
n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetesDaan Kromhout, Johanna M Geleijnse, Janette de Goede, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 27, 2007
External validity of ST elevation myocardial infarction trials: the Zwolle studiesSaman Rasoul, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
European Heart Journal|May 10, 2006
A comparison of dual vs. triple antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndrome: results of the ELISA-2 trialSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
BMC Cardiovascular Disorders|March 7, 2007
Are patients with non-ST elevation myocardial infarction undertreated?Saman Rasoul, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
Journal of the American College of Cardiology|April 20, 2004
Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Felix Zijlstra, et al.
Coronary Artery Disease|July 31, 2009
Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarctionSaman Rasoul, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
International Journal of Cardiology|October 18, 2011
Impact of ischemic time on post-infarction left ventricular function in ST-elevation myocardial infarction treated with primary percutaneous coronary interventionSunanto Ng, Jan Paul Ottervanger, Arnoud W J van 't Hof, et al.
Diabetes Care|March 29, 2006
Impact of routine stenting on clinical outcome in diabetic patients undergoing primary angioplasty for ST-segment elevation myocardial infarctionGiuseppe De Luca, Harry Suryapranata, Jorik Timmer, et al.
The American Journal of Cardiology|May 21, 2005
Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplastyGiuseppe De Luca, Nicolette Ernst, Harry Suryapranata, et al.
American Heart Journal|November 4, 2004
Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction studyGiuseppe De Luca, Harry Suryapranata, Jan-Henk Dambrink, et al.
Pageof 14